Sleep Disorders Trial, Recruiting (NCT07636850)

Sleep Disorders Trial, Recruiting NCT07636850 Sponsor: Florida State University Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07636850 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children who are currently enrolled in elementary or middle school (grades 1 through 8)
Children who are between 6 and 13 years old
Children who are able to speak and read in English

Who may not be able to join:

Children who have taken antibiotics in the last 3 months
Children who have taken prebiotics, probiotics, or postbiotics (supplements that affect gut bacteria) in the last 3 months
Children who have a food allergy to any of the foods used in the study, including nuts or almonds
Children who have an allergy to chocolate or wheat
Children who regularly eat nuts or almonds more than 2 servings per week
Children who have been diagnosed with a digestive condition such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, acid reflux, or similar gut disorders (confirm with trial site)
Children who have been diagnosed with a neurological condition such as multiple sclerosis, meningitis, or who have recently had a stroke
Children who have certain hormone-related conditions, such as uncontrolled thyroid disorders, growth hormone disorders, adrenal gland disorders, or poorly controlled diabetes (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ravinder Nagpal, PhD, Florida State University

Phone: 850-644-1829

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07636850

Sponsor: Florida State University

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 850-644-1829

More information: https://clinicaltrials.gov/study/NCT07636850

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children who are currently enrolled in elementary or middle school (grades 1 through 8)
Children who are between 6 and 13 years old
Children who are able to speak and read in English

Who may not be able to join:

Children who have taken antibiotics in the last 3 months
Children who have taken prebiotics, probiotics, or postbiotics (supplements that affect gut bacteria) in the last 3 months
Children who have a food allergy to any of the foods used in the study, including nuts or almonds
Children who have an allergy to chocolate or wheat
Children who regularly eat nuts or almonds more than 2 servings per week
Children who have been diagnosed with a digestive condition such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, acid reflux, or similar gut disorders (confirm with trial site)
Children who have been diagnosed with a neurological condition such as multiple sclerosis, meningitis, or who have recently had a stroke
Children who have certain hormone-related conditions, such as uncontrolled thyroid disorders, growth hormone disorders, adrenal gland disorders, or poorly controlled diabetes (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Florida State University

Registry

ClinicalTrials.gov

Start date

1 August 2026

Est. completion

31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Gut Microbiome Alpha and Beta Diversity Measured by 16S rRNA Gene Sequencing of Fecal Samples; Change in Oral Microbiome Alpha and Beta Diversity Measured by 16S rRNA Gene Sequencing of Oral Swabs; Change in Fecal Metabolome; Change in Serum Metabolome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov